Jones Soda Posts Record Q3, Plans Gut-Health Drinks Under Jones Labs

Jones Soda tripled Q3 revenue on Fallout Nuka-Cola and plans Jones Labs gut-health drinks, but a going-concern warning remains.

Jones Soda Posts Record Q3, Plans Gut-Health Drinks Under Jones Labs

Jones Soda just posted the biggest quarter in its history. The money didn't come from anything you'd call functional. It came from craft soda, club-store distribution, and a cola from a video game.

For the third quarter ended September 30, 2026, Jones reported revenue of $13.7 million, up 204% from $4.5 million a year earlier. The Seattle brand also swung to $471,000 in net income from continuing operations, against a $1.4 million loss in Q3 2025. In its November 10, 2026 results, Jones also said it plans gut-health innovation under the name Jones Labs. If you shop the better-for-you aisle, that's the line to watch. It's also the line with the least behind it so far.

Q3 by the Numbers

Six Jones Soda glass bottles are arranged side by side against a white background, each with a black cap and a distinct soda color
See the full Jones Soda Cane Sugar Soda product guide.
  • Revenue: $13.7 million, up 204% year over year
  • Nine-month revenue: $36.3 million, up 167% from $13.6 million
  • Gross margin: 34.4%, up from 28.9%
  • Operating income: $400,000, versus a $1.4 million operating loss
  • Adjusted EBITDA: $869,000, versus an $897,000 loss
  • Nine-month result: still a $64,000 net loss from continuing operations
  • Cash: $4.4 million as of September 30

Jones reaffirmed its fiscal 2026 outlook of net revenue above $45 million (more than 80% growth over 2025) and positive adjusted EBITDA for the year.

"The third quarter marked an important step forward for Jones Soda," said CEO Scott Harvey. "Revenue grew 204% year over year to a record $13.7 million, gross margin expanded to 34.4%, and we generated $400,000 of operating income compared with a $1.4 million operating loss a year earlier."

Nuka-Cola Carried the Quarter

The base of the business is still Jones' Cane Sugar Soda lineup. For the jump, Jones points to more club distribution, more direct-to-consumer sales, a Zero Sugar lineup in Western Canada club stores, and collaborations with Fallout and Crayola. The headliner is Bethesda's Fallout license. Jones made the game's Nuka-Cola real with the Vault-Dweller Variety 12-pack, which reached club stores like Costco ahead of Fallout Day 2026 with Nuka-Cola Quartz, Quantum, and Cranberry inside.

It's a smart play. Fandom drinks sell to people who'd never browse the soda aisle for fun. Licensed hits can also cool off fast, and the rest of the numbers show what this growth costs. Selling and marketing expense more than doubled to $2.3 million for the quarter. Inventory rose to $6.5 million from $2.7 million at the end of 2025. Year-to-date gross margin is 31%, slightly below the 32% Jones posted over the same stretch of 2025. One strong quarter carried the margin story.

Jones Labs Is Still a Plan

A black-and-white Nutrition Facts panel on a plain white background lists one 355 mL serving, 180 calories, and 46 g of added sugars
See the full Jones Soda Cane Sugar Soda product guide.

Jones says it's "expanding into functional health with planned gut-health innovation under Jones Labs." Harvey said the company is "evaluating opportunities to expand into functional health and nutrition."

That's the whole announcement. Jones hasn't named a product, shared a formula, or set a launch date, and nothing from Jones Labs is on shelves. There's no label yet, so nobody can judge what it puts in the can or how it stacks up.

It also has a crowded aisle to break into. Poppi and Olipop built the modern gut-health soda shelf, and big soda companies have since moved in. A craft soda brand known for its bottle labels and sugar colas would need a formula that clearly stands out. Gut-health soda shoppers read labels. A Jones logo and a "Labs" name won't be enough on their own.

The Going-Concern Fine Print

A Jones Soda Cane Sugar Soda display carton holds several clear glass bottles, with one Cream Soda bottle standing beside it
See the full Jones Soda Cane Sugar Soda product guide.

The balance sheet looks better than it did in January, but it's still thin. Working capital moved from a deficit of about $0.5 million at the end of 2025 to roughly $2.1 million. Jones also closed a US$765,000 private placement during the year. The business still used $2.3 million in cash from continuing operations in the first nine months, an improvement over $4.0 million a year earlier.

Jones' own outlook warns that revenue growth and operating income "do not necessarily imply positive cash flow". Its September 30, 2026 Form 10-Q also includes a substantial-doubt going-concern disclosure. In plain terms, the company's filing says there's real uncertainty about its ability to keep funding operations. Building a gut-health line from nothing takes formulation, production, and marketing money, and that's exactly where the cushion is thinnest.

Jones has earned credit for turning Nuka-Cola into actual revenue. Until Jones Labs shows a label, though, the gut-health pivot is a slide in an earnings deck that still has to compete with Poppi and Olipop.

Expanded article image